Bringing you the latest cutting-edge research and commentary in bioscience.

Cell & Gene Therapy Insights

Cell & Gene Therapy Insights

Can HypoThermosol® or CryoStor® be used in clinical applications?

 

Our biopreservation media, CryoStor® and HypoThermosol®, are utilized by a number of cell therapy groups (currently approximately 250+ regenerative medicine applications). We have a number of clinical customers that also use the solutions as excipients without wash for patient application of their cell therapies. The media solutions are not classified as drugs or devices, and therefore do not carry specific therapeutic regulatory approvals. Within their classification as ancillary materials in a customer process (or excipient if utilized in this manner by a customer), they are reviewed within the context of the customer process. Each group certainly needs to appropriately qualify the ancillary or excipient usage within their specific cell product application, but we can provide you with some clinical supporting information for your review. For clinical applications, there are several models being utilized by customers relevant to CryoStor® and HypoThermosol®:

Within the Evidence Page on our website, there is a list of customer clinical applications using CryoStor® and HypoThermosol®, including if utilized as an excipient. Please visit us at http://www.biolifesolutions.com/evidence/ and click the “BioPreservation Media Products in Customer Clinical Trials” tab for the most current list.

Twitter IconVisit Our Blog